03 Feb 2025
// PRESS RELEASE
11 Dec 2024
// PRESS RELEASE
17 Jul 2024
// PR NEWSWIRE
SPI Pharma has been solving formulation challenges using superior functional materials.
About
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
World Vaccine CongressWorld Vaccine Congress
Industry Trade Show
Attending
13-16 October, 2025
SupplySide WestSupplySide West
Industry Trade Show
Attending
27-30 October, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
World Vaccine CongressWorld Vaccine Congress
Industry Trade Show
Attending
13-16 October, 2025
SupplySide WestSupplySide West
Industry Trade Show
Attending
27-30 October, 2025
VLOG #PharmaReel
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-seqens-evonik-make-strategic-moves-new-guidelines-deal-with-contamination
03 Feb 2025
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/enhancing-patient-experience-with-ultraburst-the-ultimate-odt-solution/
11 Dec 2024
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/beyond-pharma-spi-pharma-s-impact-across-industries/
17 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/spi-pharma-inc-and-inimmune-corp-partner-to-develop-and-commercialize-innovative-vaccine-adjuvant-systems-302198093.html
08 Jan 2024
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/embracing-patient-centric-formulations-for-a-healthier-tomorrow/
13 Oct 2023
// PRESS RELEASE
https://www.spipharma.com/en/insights-and-events/news-blog/offering-broader-access-to-sustainable-and-scalable-pharma-grade-saponin-adjuvants/
10 Jul 2023
// EXCIPACT
https://www.excipact.org/news-reader/spi-pharma-in-grand-haven-usa-receives-excipact-gmp-certification-as-pharmaceutical-excipient-supplier.html
Excipients
Excipients by Ingredients
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : AHMC 0600 is a co-processed aluminum hydroxide and magnesium carbonate powder used in immediate-relief antacid tablet formulation.
Pharmacopoeia Ref : NA
Technical Specs : Apparent Density: 0.30-0.40 (g/mL)
Ingredient(s) : Aluminum Hydroxide Excipient; Magnesium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : AHMC 0611 is a co-processed aluminum hydroxide & magnesium carbonate micronized powder used in immediate-relief antacid tablets & liquid suspensions.
Pharmacopoeia Ref : NA
Technical Specs : Tapped NMT: 0.2
Ingredient(s) : Aluminum Hydroxide Excipient; Magnesium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Aluminum hydroxide dried gel product (powder) 0200 is typically used in wet granulation processes to manufacture antacid tablets.
Pharmacopoeia Ref : USP, EP
Technical Specs : Tapped Density: 0.16-0.25; PSD D50: 12 µm
Ingredient(s) : Aluminum Hydroxide Excipient
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids
Excipient Details : DC CoDried Powders are pre-formulated, DC aluminum hydroxide & magnesium hydroxide products used in the manufacturing of chewable antacids tablets.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Aluminum Hydroxide Excipient; Magnesium Hydroxide Excipient
Dosage Form : Gel, Suspension
Grade : Oral
Application : Thickeners and Stabilizers
Excipient Details : SPI® VAC Gels are based on highly engineered pseudo-boehmite and are used as vaccine adjuvants.
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids
Excipient Details : DC CoDried Powders are pre-formulated, DC aluminum hydroxide & magnesium hydroxide products used in the manufacturing of chewable antacids tablets.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Aluminum Hydroxide Excipient; Magnesium Hydroxide Excipient
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Magnesium Hydroxide powder 5100 is used in wet granulation tableting applications for the production of antacid tablets and digestive aids.
Pharmacopoeia Ref : USP, Ph. Eur.
Technical Specs : Tapped Density: 0.68-0.84
Ingredient(s) : Magnesium Hydroxide Excipient
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Magnesium Hydroxide powder 5300 is used in wet granulation tableting applications for the production of antacid tablets and digestive aids.
Pharmacopoeia Ref : USP, Ph. Eur.
Technical Specs : Tapped Density: 0.60-0.90
Ingredient(s) : Magnesium Hydroxide Excipient
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Application : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient; Starch
Excipients By applications
Inspections and registrations
ABOUT THIS PAGE
SPI Pharma is a supplier offers 10 products (APIs, Excipients or Intermediates).
Find a price of Magnesium Hydroxide bulk with DMF, CEP offered by SPI Pharma
Find a price of Aluminum bulk with CEP offered by SPI Pharma
Find a price of Calcium Carbonate bulk with DMF offered by SPI Pharma
Find a price of Magnesium Hydroxide bulk with CEP offered by SPI Pharma
Find a price of Aluminium Hydroxide bulk offered by SPI Pharma
Find a price of Calcium Carbonate bulk offered by SPI Pharma
Find a price of Magaldrate bulk offered by SPI Pharma
Find a price of Magnesium Carbonate bulk offered by SPI Pharma
Find a price of Magnesium Hydroxide bulk offered by SPI Pharma
Find a price of Paracetamol bulk offered by SPI Pharma